Role of Oral Microbiota as Predictive Biomarkers for Radiation-Induced Toxicities.
DOI:
https://doi.org/10.51168/fdj2hw50Keywords:
Oral microbiota, radiotherapy, head and neck cancer, oral mucositis, xerostomia, predictive biomarkersAbstract
Background:
Radiotherapy for head and neck cancers commonly causes oral toxicities that can affect treatment tolerance and quality of life. Alterations in oral microbiota may help identify patients at increased risk of these complications.
Methods:
A retrospective observational study was conducted at Burdwan Medical College and Hospital between June 2024 and July 2025. Medical records of 79 patients with histologically confirmed head and neck cancer who completed definitive radiotherapy, with or without concurrent chemotherapy, were reviewed. Demographic characteristics, clinical parameters, treatment details, oral microbiological findings, and radiation-induced toxicities graded according to the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 were retrieved. Associations between microbial profiles and treatment-related toxicities were analyzed using chi-square test, Student's t-test, and multivariate logistic regression. Statistical significance was considered at p <0.05.
Results:
Among 79 patients, 53.2% developed Grade II–III oral mucositis, while xerostomia and oral candidiasis occurred in 44.3% and 27.8% of patients, respectively. Patients demonstrating higher baseline colonization with Candida species and pathogenic Gram-negative bacteria experienced significantly greater rates of severe mucositis and xerostomia (p<0.05). Reduced abundance of commensal Streptococcus species was independently associated with increased radiation-induced toxicity. Multivariate analysis identified baseline dysbiosis as an independent predictor of Grade II–III mucositis (adjusted OR 3.42, 95% CI 1.48–7.92, p=0.003).
Conclusion:
Baseline oral microbial dysbiosis was associated with radiation-induced oral toxicities and may help identify patients at increased risk of severe treatment-related complications.
Recommendation:
Prospective multicenter studies incorporating microbiome sequencing and longitudinal microbial profiling are recommended to validate these findings and support the development of microbiota-based preventive strategies.
References
1. Reis M, Pasto A, Ng T, Patel V, Guerrero T, Sears C, et al. The microbiota and radiotherapy for head and neck cancer : What should clinical oncologists know ? Cancer Treat Rev [Internet]. 2022;109(August):102442. Available from: https://doi.org/10.1016/j.ctrv.2022.102442
2. Queipo-ortu MI. Influence of the microbiome on radiotherapy-induced oral mucositis and its management : A comprehensive review. Fern a ˜ a Fern a Yolanda Lupi a. Oral Oncol. 2023;144(June):1-9. https://doi.org/10.1016/j.oraloncology.2023.106488
3. Palkovsky M, Modrackova N, Neuzil-bunesova V, Liberko M, Soumarova R. The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome : Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator. In Vivo (Brooklyn). 2025;54:37-54. https://doi.org/10.21873/invivo.13803
4. Song J, Xia LEI. Oral microbiota : Roles and treatment in radiation injury ( Review ). Oncol Lett. 2025;30(472):1-12. https://doi.org/10.3892/ol.2025.15255 https://doi.org/10.3892/ol.2025.15218 https://doi.org/10.3892/ol.2025.15055
5. Yi Y, Lu W, Shen L, Wu Y, Zhang Z. The gut microbiota as a booster for radiotherapy : novel insights into radio-protection and radiation injury. Exp Hematol Oncol [Internet]. 2023;12(48):1-19. Available from: https://doi.org/10.1186/s40164-023-00410-5
6. Dong J, Li Y, Xiao H, Dong J, Li Y, Xiao H, et al. Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models ll Oral microbiota affects the efficacy and prognosis of radiotherapy for colorectal cancer in mouse models. Cell Reports [Internet]. 2021;37(4):109886. Available from: https://doi.org/10.1016/j.celrep.2021.109886 https://doi.org/10.1016/j.celrep.2021.109886
7. Head M, Squamous N, Porosnicu M. A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers. Cancers (Basel). 2022;14(4116):1-27. https://doi.org/10.3390/cancers14174116
8. Zhu X, Yang X, Chao Y, Zheng H, Sheng H, Liu H, et al. The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma. EBioMedicine [Internet]. 2017;18:23-31. Available from: http://dx.doi.org/10.1016/j.ebiom.2017.02.002 https://doi.org/10.1016/j.ebiom.2017.02.002
9. Lorenzo M, Georgopulos A, Ramera M, Andreuccetti J, Guerini AE, Bozzola AM, et al. Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers : What Radiation Oncologists Need to Know - A Review on Behalf of the Italian Association of Radiobiology ( AIRB ). Curr Issues Mol Bio. 2025;47(265):1-15. https://doi.org/10.3390/cimb47040265
10. Ma S, Li X, Shang S. Targeting gut microbiota and metabolites in cancer radiotherapy Targeting gut microbiota and metabolites in cancer radiotherapy. Clin Transl Med. 2025;15(September):1-29. https://doi.org/10.1002/ctm2.70481
11. Wu B, Anqi Zhao, Wenlu Chen, YZ, Wenbo Zhang, Yiwen Zhang QH, Yao N, Shuangping Zhang, Jianchun Duan NL, 2 JC. Microbiota-mediated modulation of radiosensitivity : mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics. Front Microbiol. 2025;16(December):1-20. https://doi.org/10.3389/fmicb.2025.1689735
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr.Prince Prakash, Dr .Surjya Shankar Meher, Dr.Rajlaxmi Paikray, Dr. Ayesha Sitam, Dr.Suparna Ghosh Ray
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
